TCT 2024 Late-Breaking Science Collection
Published: 17 October 2024
-
Views:
2695
-
Likes:
7
-
Views:
2695
-
Likes:
7
-
7m 10s -
4m 10s -
4m 19s -
5m 36sPart 2 | Session 4 MATTERHORN: Transcatheter Repair Versus Surgery in Mitral Regurgitation -
3m 34sPart 2 | Session 5 INFINITY-SWEDEHEART: DynamX Bioadaptor in Patients with Complex Lesions -
3m 43s -
3m 33s -
3m 56s -
6m 32s
-
6m 24sPart 3 | Session 1 5 Trials That Will Change My Practice with Dr Mirvat Alasnag -
5m 1sPart 3 | Session 2 2 Trials That Will Change My Practice with Dr Sahil Parikh
Overview
Keep informed with our video collection unveiling data from the Transcatheter Cardiovascular Therapeutics Conference in Washington. With expert insights on late-breaking trials and critical findings, you won't want to miss our #TCT24 coverage.
- For practice-focused reviews of the most anticipated trials, watch our recurring View From the Thoraxcenter series, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).
- Our short Expert Interviews with select faculty offer focused data analysis and take-home messages for practice.
- To delve deeper into insights on the most pertinent trials, catch our Highlights.
Dive into the latest cardiology research with our upcoming TCT Conference coverage.
More from this programme
Part 1
View From the Thoraxcenter: What's Hot at TCT 24?
Part 2
Expert Interviews
About the episode
Which trials will have the greatest impact at TCT 2024?
Get a head start on the biggest cardiovascular breakthroughs of TCT 24! Leading experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) offer an exclusive preview of the most anticipated late-breaking studies set to be unveiled at TCT Conference 2024. Discover their in-depth analysis of these studies and gain invaluable insights ahead of the curve.
TCT Conference 2024 Hot line Trials Included:
ECLIPSE (00:31)
FAVOR III (03:38)
FLASH (05:48)
DCB-BIF (08:04)
CONFIRM II (10:55)
EVOLVE (14:02)
TAVR UNLOAD (20:29)
PEERLESS II (22:29)
TRISCEND II (25:32)
ACCESS TAVI (27:46)
ALIGN AR (30:32)
CLEAR SYNERGY (32:14)
Co-STAR (35:31)
Stay tuned for Radcliffe Cardiology's in-depth coverage of these and other pivotal trials from TCT Conference 2024.
Faculty Biographies
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Comments